We previously showed that topical flagellin induces profound mucosal innate protection in the cornea against microbial infection, a response involving multiple genes and cell types. In this study, we used a Candida albicans (CA)-C57BL/6 mouse keratitis model to delineate the contribution of CXCL10-and CXCR3-expressing cells in flagellin-induced protection. Flagellin pretreatment markedly enhanced CXCL10 expression at 6 h post CA infection (hpi), but significantly dampened CXCL10 expression at 24 hpi. At the cellular level, CXCL10 was expressed in the epithelia at 6 hpi in flagellin-pretreated corneas, and concentrated at lesion sites 24 hpi. CXCR3-expressing cells were detected in great numbers at 24 hpi, organized within clusters at the lesion sites in CA-infected corneas. CXCL10 or CXCR3 neutralization increased keratitis severity and dampened flagellininduced protection. CXCR3-positive cells were identified as NK cells, the depletion of which resulted in severe CA keratitis. Contributions from NK T-cells were excluded by finding no change in flagellin-induced protection in Rag1 KO mice. Recombinant CXCL10 inhibited CA growth in vitro and accelerated fungal clearance and inflammation resolution in vivo. Taken together, our data indicate that epithelium-expressed CXCL10 plays a critical role in fungal clearance and that CXCR3-expressing NK cells contribute to CA eradication in mouse corneas. Eur. J. Immunol. 2014Immunol. . 44: 2667Immunol. -2679 trauma or surgery, during periods of immunosuppression such as prolonged corticosteroid use, and during topical anesthetic abuse [1] [2] [3] [4] [5] [6] . Although rare, the incidence of fungal keratitis has increased in recent years, especially in contact lens wearers [7, 8] . To date, there is no clinically amenable measure to prevent fungal keratitis. Current practice in treating fungal keratitis involves the use of topical antifungal drops such as natamycin and amphotericin B. Topical antifungals can cause toxicity such as punctate keratitis, chemosis, and recurrent corneal epithelial erosions [9] . Hence, understanding the pathogenesis of fungal keratitis and host responses will aid in identifying new therapeutics to improve the prognosis of this condition.
Introduction
Candida albicans (CA) is a commensal fungus of the normal flora, yet may cause opportunistic infections of the cornea following trauma or surgery, during periods of immunosuppression such as prolonged corticosteroid use, and during topical anesthetic abuse [1] [2] [3] [4] [5] [6] . Although rare, the incidence of fungal keratitis has increased in recent years, especially in contact lens wearers [7, 8] . To date, there is no clinically amenable measure to prevent fungal keratitis. Current practice in treating fungal keratitis involves the use of topical antifungal drops such as natamycin and amphotericin B. Topical antifungals can cause toxicity such as punctate keratitis, chemosis, and recurrent corneal epithelial erosions [9] . Hence, understanding the pathogenesis of fungal keratitis and host responses will aid in identifying new therapeutics to improve the prognosis of this condition.
Using various murine models of fungal keratitis, recent research indicates that innate immunity, primarily mediated by various TLRs and the MyD88 signaling pathway, plays a key role in the host response to fungal infection [10, 11] . We have developed a mouse experimental CA keratitis model [12, 13] to show that pre-exposure of the cornea to TLR5 ligand flagellin induces a strong innate defense and promotes robust resistance to infection in the cornea [14] . The activation of innate immunity after TLR5 stimulation is attributed to flagellin-induced reprogramming of gene expression in corneal epithelial cells (CECs) in response to pathogens, including diminished inflammatory response to CA and at the same time, enhanced production of antimicrobial peptides (AMPs) in a TLR5-dependent manner [14] [15] [16] [17] . Our data suggested that topical applied flagellin functions as an immunostimulant to activate the innate defense apparatus, resulting in resistance to infectious keratitis [14, 18, 19] . More recently, we have shown that flagellin pretreatment followed by Pseudomonas (P) aeruginosa infection resulted in 890 genes upregulated and 37 genes downregulated [17] . At the cell levels, neutrophils were shown to be required for flagellin-induced protection against P. aeruginosa and CA [14, 19] . The depletion of neutrophils resulted in P. aeruginosa dissemination from the eye to the entire body and in death within 2 dpi and in corneal perforation in otherwise self-healing, CA-infected corneas of C57BL/6 mice [14, 19] . Others have shown the importance of macrophages in corneal defense against fungal and bacterial pathogens [20, 21] . Hence, flagellin-induced protection may have the participation of most, if not all, innate immune cell types as well as the participation of residential CECs and stromal fibroblasts. As flagellin, a virulent Gram-negative protein, is unlikely to be used clinically, identifying the downstream effectors that participate in flagellin-induced fungus killing is of great importance.
In an effort to study transcriptional regulation, we identified interferon regulatory factor 1 (IRF1) as one of the most highly upregulated transcription factors in response to P. aeruginosa infections in vitro and in vivo [22] . We showed that IRF1, by regulating CXCL10 expression, plays a role in corneal innate immune response. Moreover, we identified IFN-γ produced by NK cells as a key factor that augmented IRF1 and CXCL10 expression in flagellin-pretreated corneas [22] . In another study, we also reported great upregulation of CXCL10 in response to epithelial wounding in a DC-related manner in mouse CECs [17] . CXCL10 is a member of the IFN-inducible tripeptide motif Glu-Leu-Argnegative (ELR − ) CXC chemokines [23] . This chemokine, along with CXCL9 and CXCL11, signals through a G-protein-coupled receptor, CXCR3 that is expressed primarily on activated T lymphocytes and NK cells, and functions primarily in the recruitment of these cells to the sites of infection and inflammation [24] [25] [26] . In addition to their roles in leukocyte recruitment, CXCR3 ligands exert direct antimicrobial effects that are comparable to the effects mediated by cationic AMPs, including defensins [27] . To date, whether CXCL10 participates in corneal innate defense against fungal infection remains to be determined. In this study, we sought to better understand the molecular mechanisms underlying flagellin-induced protection and corneal innate immunity using an experimental Candida keratitis model. We showed that while CXCL10 was mostly expressed in CECs, especially at the early stage of infection, CXCR3 was expressed only in the infiltrating cells, most of which were NK1.1-positive. Neutralizing CXCL10, CXCR3 or depleting NK cells impaired innate defense against CA in the cornea. Our results reveal that the CXCL10-CXCR3 signaling pathway plays a role in mucosal innate immunity against fungal infection and that CXCL10 might be developed as an adjuvant treatment for microbial keratitis.
Results

Flagellin-induced protection against CA is T-and B-cell independent
As flagellin-induced protection can be detected as early as 6 hpi (where hpi is hours post CA infection) and was very apparent at 24 hpi, and the outcome of infectious keratitis was strongly related to the pathogen load at 1 dpi [14, 19, 28] , we suspect that the protection is mostly related to innate immunity. To test this hypothesis, we used Rag1 KO (Rag1KO mice that lack all T cells and B cells, in comparison with WT C57BL/6 mice, to determine the role of adaptive immunity in flagellin induced protection. We previously showed that 10 5 CA (human isolate strain SC5314) was sufficient to cause fungal keratitis in C57BL/6 mice [14] . Figure 1A shows a normal C57BL/6 mouse eye, and eyes infected with CA at 24 hpi, with or without flagellin pretreatment. The protective effects of flagellin pretreatment were evident by the presence of small areas of opacification in flagellin-pretreated eyes, whereas the control-infected cornea (PBS) was 50% covered with patches of opacification. The severity of keratitis under different experimental conditions was quantitated with clinical scoring. The CA keratitis in C57BL/6 mice was moderate at 1 dpi and exhibited mild eye diseases at 5 dpi. There were no differences in clinical scores, opacification of the cornea, PMN infiltration indicated by myeloperoxidase (MPO) enzyme activities, and the expression of proinflammatory cytokine CXCL2 between Rag1KO and C57BL/6 mice. The flagellin-pretreated corneas in these mice remained keratitis free at 5 dpi. Thus, we conclude that flagellin-induced protection does not require functional B or T cells, but rather primarily involves innate immune cells, including neutrophils [14, 19] and NK cells.
Flagellin pretreatment regulates Cxcl10 and Cxcr3 expression in corneas in response to CA infection
Our recent study of P. aeruginosa keratitis identified CXCL10 as a major chemokine induced by infection and augmented by flagellin pretreatment in an IFN-γ and IRF1-dependent manner [22] . To determine if CXCL0 also plays a role in corneal innate defense against fungal pathogens, we assessed the expression of Cxcl10 and its receptor Cxcr3 in response to fungal infection, with or without flagellin pretreatment (Fig. 2) . In normal, homeostatic corneas (NL), no expression of Cxcl10 and Cxcr3 was detected. Flagellin-pretreated, but not PBS-instilled, corneas expressed detectable Cxcl10 and Cxcr3 at 24 h posttreatment, prior to pathogen inoculation. CA infection triggered the expression of both Cxcl10 and Cxcr3, and flagellin pretreatment had disparate effects on the expression of Cxcr3 (downregulated) and Cxcl10 (upregulated) in C57BL/6 mouse corneas at 6 hpi. At 24 hpi, both Cxcl10 and Cxcr3 were more abundant in C. albicans infected corneas, but flagellin pretreatment dampened their expression ( Fig. 2A) . Robust upregulation of Cxcl10, but not other Cxcr3 ligands, Cxcl9 and Cxcl11, and Cxcr3 in response to infection, and their suppression by flagellin pretreatment, were also detected by real-time PCR (Fig. 2B) . The dramatic downregulation of Cxcl10 and Cxcr3 in flagellin-pretreated corneas was consistent with a lack of any sign of infection and/or inflammation in the treated corneas at 1 dpi shown in Figure 1 .
Flagellin pretreatment alters CXCL10-CXCR3 signaling by increasing the expression of CXCL10
We next investigated if Cxcl10 and Cxcr3 were expressed at the protein level and how they were distributed in CA-infected corneas, with or without flagellin pretreatment, using immunohistochemistry (Fig. 3) . No CXCL10-or CXCR3-positive cells were detected in the normal, homeostatic corneas (Fig. 3A) . Flagellin pretreatment through topical application to needle injury sites (Fig. 3C ), but not injury itself (Fig. 3B) , was sufficient to induce the expression of CXCL10 at the basal cell layer of the stratified Figure 2 . Topical flagellin affects expression of Cxcl10 and Cxcr3 in C57BL/6 mouse corneas. C57BL/6 mouse corneas were flagellinpretreated and CA-inoculated as described in Figure 1 . The naïve (NL) and CA-infected corneas with or without flagellin pretreatment for 24 h were excised at 0 (no fungal inoculation, 0 h), 6, and 24 hpi, and subjected to (A) RNA isolation and RT-PCR analysis for Cxcl10 (L10) and Cxcr3 (R3), with Gapdh (G3) as an internal control or (B) real-time PCR for Cxcl9, Cxcl10, Cxcl11, and Cxcr3. The fold increase over that of the naïve corneas (value 1) in (B) is the mean + SD of three samples for each condition with β-actin as the internal control for normalization. The results are representatives of two independent experiments. epithelia and of CXCR3 underneath the epithelial layer, suggesting paracrine signaling. At 6 hpi, there was a clear increase of CXCL10 in all epithelial cell layers in CA-infected corneas with a few CXCR3-positive cells in the stroma (Fig. 3D) . Consistent with the PCR results, flagellin pretreatment augmented CA-induced CXCL10 expression in all CECs, with a few cells strongly expressing CXCR3 in the stroma (Fig. 3E ) at 6 hpi. At 24 hpi, epithelial lesions were detected in the infected corneas. In the control, PBS-treated corneas, there was a large lesion with reduced epithelial cell layers. The CECs surrounding the lesion expressed high levels of CXCL10, while CXCR3-positive cells, many of which were in clusters, were primarily detected in the stroma (Fig. 3F) . In flagellin-pretreated corneas at 24 hpi, a portion of the epithelium became thicker, assumed to be the entering site of invading CA; there were strongly CXCL10-stained cells (CXCL10 high ) in the epithelial layer, many of which were at the apical side of the thickening site, and in the stroma, mostly at the posterior side. A cluster of CXCR3-positive cells was inserted into the epithelium (Fig. 3G ). In both CA-infected corneas with or without flagellin pretreatment at 24 hpi, CXCR3-positive cells were only found where epithelial lesions or abnormalities were detected. The overall staining intensity of CXCL10 and CXCR3 in flagellin-pretreated corneas ( Fig. 3G ) is much less than that in the control (Fig. 3F ) at 24 hpi. The expression patterns of CXCL10 and CXCR3 detected by immunohistochemistry were consistent with that detected by real-time PCR (Fig. 2B ).
CXCL3-positive cells around lesion sites are CXCL10-positive NK cells
We next investigated cell type(s) that express CXCL10 and CXCR3 in CA-infected corneas with or without flagellin pretreatment (Fig. 4) . Our previous work revealed that neutrophils play a key role in eradicating invading pathogens, including CA [14, 19] .
To assess the potential involvement of other innate immune cells, such as NK, macrophages, and DCs in fungal keratitis, we prescreened CA-infected corneal sections and found that among these cell types, NK1. 
CXCL10-CXCR3-mediated signaling is required for fungal clearance in the cornea
Having shown that both CXCL10 and CXCR3 were expressed in CA-infected corneas at 24 hpi, we next investigated if CXCL10 functions as an AMP or as a signaling molecule that involves its receptor CXCR3 by Ab-mediated functional neutralization (Fig. 5) . The CXCL10 or CXCR3 neutralizing antibodies, along with control rabbit IgG, were injected into subconjunctival spaces 4 h prior to flagellin pretreatment for 24 h, followed by CA inoculation. As shown in Figure 5 , the corneas of the control (unspecific IgG injected, PBS instilled corneas) were partially covered with opacification at 1 dpi while flagellin pretreatment protected the C57BL/6 mouse corneas from CA infection (Fig. 5A ). The CXCL10-or CXCR3-neutralized corneas had much more severe keratitis, with . CXCL10 and CXCR3 expression and distribution in CA-infected corneas with or without flagellin pretreatment. C57BL/6 mouse corneas were pretreated with or without topical flagellin for 24 h, followed by CA inoculation as described in Figure 1 . At 0 (no bacterial inoculation), 6, and 24 h postinoculation, corneas (n = 3 for each condition) were collected, embedded in Optimal Cutting Temperature (OCT), and sectioned. The sections were subjected to immunohistochemical analysis with rabbit anti-mouse CXCL10 (1:100), with DAPI staining for nuclei of the same section at left and CXCR3 (1:250) with DAPI staining at right. Arrowheads indicate positive cell clusters. Two independent experiments were performed, one representative image for each condition is presented.
the whole corneas covered with opacification of different intensity in the control mice. Moreover, there was also partial corneal melting (arrows, Fig. 5A ) in CXCL10-or CXCR3-neutralized corneas, with clinical scores >10, indicating severe keratitis (Fig. 5B) . While flagellin-induced protection was diminished when CXCL10 or CXCR3 were neutralized, the severity of keratitis was less in the flagellin-pretreated corneas compared with the counterparts of the control, PBS-treated ones, with clinical scores of approximately 6 (moderate keratitis). Consistent with the severity of keratitis, both CXCL10-and CXCR3-neutralized corneas had much greater numbers of CA compared with IgG-injected corneas. Surprisingly, neutralizing CXCR3 had a significantly higher fungal burden (Fig. 5C ) while exhibiting similar effects on PMN infiltration (Fig. 5D ) and CXCL2 expression (Fig. 5E ), compared to CXCL10 neutralized.
NK cells are important for corneal innate defense against CA infection
Since NK cells expressed CXCR3, we next investigated the role of NK cells in fungal clearance and PMN infiltration by the subconjunctival injection of NK1.1-neutralizing Ab (Fig. 6 ). Corneas injected with NK1.1 had much more severe keratitis (Fig. 6A ) at 1 dpi, with opacification covering the entire cornea, severe ocular surface irregularity, signs of inflammation in aqueous humor, and neovascularization. The much small size of NK1.1-treated eyes was indicative of the cornea near perforation. Figure 6B showed that the subconjunctival injection of NK1.1 greatly reduced the number of cells expressing CXCR3; the staining intensity of these CXCR3-positive infiltrated cells (Fig. 6B, i and ii) was also relatively lower compared with IgG-treated corneas, suggesting the reduction or depletion of NK cells. The NK1.1-treated cornea sections were stained with FITC-labeled NK1.1, four lightly stained cells were detected (arrows, Fig. 6B , iv) in NK1.1-treated corneas while large number of NK1.1-positive cells were observed in IgGinjected controls (Fig. 6B, iii) . Thus, the subconjunctival injection of NK1.1 resulted in the depletion of NK cells. Functionally, NK-cell depletion resulted in great thinning of the cornea (ulceration, Fig. 6B , ii and iv), consistent with the average clinical score >10 (Fig. 6C) , indicating severe keratitis. Plate counting revealed a small increase in fungal burden in NK-cell depleted corneas (1.37-fold) (Fig. 6D ). PMN infiltration determined by MPO assay was also significantly higher in NK-depleted corneas (Fig. 6E) . Taken together, NK-cell depletion resulted in severe fungal keratitis in C57BL/6 mouse corneas.
In vitro fungicidal activity of CXCL10
CXCR3 ligands have been shown to possess the ability to kill microorganisms, mostly bacteria [23, 31, 32] . To determine if CXCL10 can kill CA, as demonstrated for CCL20 [32] , we performed in vitro fungus killing assay and found that under physiological condition (PBS), recombinant human CXCL10 killed CA in a concentration-dependent manner (Fig. 7) .
Recombinant CXCL10 dampens CA keratitis
As flagellin-induced protection was associated with the endogenous expression of CXCL10, and human CXCL10 is capable of killing CA in vitro, we next investigated whether exogenous CXCL10 can be used to protect corneas from fungal keratitis. Two routes of application were used. In one group, CXCL10 (500 ng in 5 μL) was subconjunctivally injected into mice with PBS solution as the control 4 h prior to CA inoculation, followed by the topical application of 5 μL PBS with or without 100 ng CXCL10 at 4 hpi (Fig. 8) . At 1 dpi, the PBS-treated eyes showed keratitis, whereas the CXCL10-treated corneas exhibited low levels of inflammation with a few small and faint areas of opacification (Fig. 8A) . Moreover, exogenous CXCL10 significantly decreased the fungal burden (Fig. 8B ), PMN infiltration (Fig. 8C) , and CXCL2 expression (Fig. 8E ) at 1 dpi. In the second group, CXCL10 was dissolved in Soothe emollient eye drops for extended retention at the ocular surface; 5 μL containing 25 ng/μL CXCL10 was topically applied to the infected corneas starting at 6 hpi, five times for the first day and three times daily until day 7. Figure 9 shows the images of infected corneas at day 3, 5, and 7 after CXCL10 treatment (dpt). At 3 dpt (88 h postinfection), the control, Soothe instilled corneas, displayed dense opacification localized near the center of the cornea, while the CXCL10-treated cornea had less than half of the cornea covered with a small central ring of dense opacification. At day 5, there was improvement for both conditions. In Soothe-treated eyes, some peripheral areas were now transparent, but a central dense opaque area persisted, whereas the density of opacification in CXCL10-treated eyes was substantially decreased (Fig. 9A) . At 7 dpt, the treated cornea was almost free of diseases, while the control eye remained in a state of moderate keratitis. Figure 9B shows the clinical scores of these two groups over 7 days (n = 5); in each day examined, CXCL10-treated corneas had significantly less keratitis than in eyes instilled with Soothe alone. . CA keratitis occurs upon local neutralization of CXCL10 or CXCR3. C57BL/6 mouse corneas were pretreated with flagellin or PBS at −24 h, as described in Figure 1 . At −6 h, CXCL10-or CXCR3-neutralizing antibodies (2.5 μg/5 μL), with the same dosage of rabbit IgG as the control, were injected into the subconjunctival space, followed by CA inoculation at 0 h. Eyes were (A) photographed and (B) scored at 24 hpi. (C) Mice were then euthanized, the corneas were excised and subjected to fungal plate counting with the results presented as CFU (×1000 CA per cornea). In (B) and (C), each symbol represents an individual mouse and mean ± SD are indicated with horizontal lines. (D) MPO determination (units/cornea) and (E) CXCL2 ELISA were performed using corneal supernatants. Results in (D) and (E) show mean + SD and are representative of two independent experiments (n = 5 each) and indicated, *p < 0.05, **p < 0.01 (one-way ANOVA).
Discussion
Using flagellin as an immunostimulant to activate innate immunity and CA as a model pathogen, we report here that both CXCL10 and CXCR3 become upregulated in the cornea in response to CA. Flagellin pretreatment resulted in CXCL10 expression in basal epithelial cells and CXCR3 expression in the subbasal stroma in uninfected corneas, and in augmented CXCL10 expression and in the altered distribution of CXCR3-expressing cells in infected corneas. The highly elevated expression of CXCL10 by flagellin pretreatment may contribute to the elimination of invading pathogens within CXCL10-expressing epithelium, probably due to reduced pathogen burden (fourfold decrease at 6 hpi and eightfold decrease at 24 hpi [14] ), which consequently reduced the need for infiltrated cells. Finally, we showed the therapeutic effects of recombinant CXCL10 in preventing corneal infection and in accelerating the resolution of CA-induced inflammation. Taken together, our study for the first time reveals that while epithelial CXCL10 is fungicidal, the CXCL10-CXCR3 signal pathway plays a role in the recruitment and activation of NK cells, which contribute to innate defense against CA keratitis. Our previous studies unraveled a part of the underlying mechanisms for flagellin-induced protection, including the persistent induction of antimicrobial CRAMP (human LL-37 homolog) in corneal epithelia and the infiltration of a small number of neutrophils in the stroma prior to pathogen inoculation [14, 19, 33] .
In this study, we demonstrated that flagellin exposure resulted in the induction of CXCL10 in basal epithelial cells and its receptor CXCR3 underneath the CXCL10-positive cells at the anterior side of the stroma. Interestingly, we observed that flagellin pretreatment enhanced the expression of CXCL10 at the early stage of infection (6 hpi) but suppressed it at a later stage (24 hpi). CXCL9, CXCL10, and CXCL11 are chemokines that are rapidly induced upon infection and upon TLR activation in epithelial cells, endothelial cells, and monocytes [34, 35] . In this study, we showed that among the three CXCR3 ligands, only CXCL10 is expressed in CECs in response to CA infection in C57BL/6 mice. While CXCL10 expression is augmented, CXCR3 expression was suppressed by flagellin pretreatment at 6 hpi. Hence, the flagellinaugmented expression of CXCL10, but not its receptor CXCR3, is likely the result of reprogramming rather than the additive effects of flagellin and CA challenge [17] . CXCL10 is a multifunctional chemokine, exerting direct antimicrobial effects against bacteria as effective as β-defensin [36, 37] . Whether CXCL10 has fungicidal activity has not been directly assessed, but it can be inferred from that of CL20 [32] . In this study, we demonstrate that recombinant CXCL10 possesses moderate fungicidal activity under physiological conditions. As significant fungal clearance was observed at 6 hpi in flagellin-pretreated corneas [17] when the infiltration of immune cells, particularly CXCR3-positive cells, are sparse (Fig. 3) . Hence, we suggest that although the in vitro fungicidal activity is moderate, the augmented expression of CXCL10 in the epithelium contributes to flagellin-induced innate protection by direct killing of the fungi at the epithelial layer. This was confirmed by subconjunctival injection of CXCL10, followed by a topical application that nearly abolished CA keratitis. Other AMPs shown to be involved include CRAMP (human LL-37) and β-defensins [14, 38, 39] . The elimination of invading pathogens at the early stages of infection induced by flagellin pretreatment is likely to result in less infiltration of professional immune cells, including PMN [14] , NK cells, macrophages, resulting in reduced inflammation, and, as such, less or no tissue damage.
CXCL10 signals through CXCR3, and acts primarily in the recruitment of NK cells and plasmacytoid DCs to the sites of infection and inflammation [26, 36, 37, 40] . Several studies of HSV-1 keratitis revealed that the CXCL10 but not CXCL9 and CXCL11, CXCR3 signaling axis plays a critical protective role in the mouse model of viral keratitis [41, 42] . To determine if CXCL10 primarily works as a fungicidal molecule, or as a chemokine that acts through its engagement with CXCR3, we used anti-CXCL10 or anti-CXCR3 antibodies and found that neutralizing either CXCL10 or CXCL3 resulted in significantly higher fungal load and greater inflammation than the control. Surprisingly, neutralizing CXCR3 resulted in a greater increase in fungal burden in both the control and flagellin-pretreated corneas, suggesting that CXCL10-mediated signaling and/or recruitment are more important than its fungicidal activity at 1 dpi. Our results differ from what has been reported in a murine model of inhalational anthrax infection, where the neutralization of CXCL10, but not its receptor CXCR3, increased bacterial burden [36] , suggesting that CXCL10 acts as an important AMP in the anthrax infection model. Importantly, neutralizing CXCL10 or CXCR3 impaired, but did not abolish, flagellin-induced protection, suggesting that CXCL10-independent effects of flagellin, including the augmented expression of other AMPs, such as CRAMP and defensins, and the presence of innate immune cells such as PMN at the time of pathogen-host interaction [14, 19] . The effects of neutralizing CXCR3 on the severity of CA keratitis is likely due to the effects of CXCL10-mediated recruitment of professional innate immune cells. Indeed, we observed greatly increased NK cells in CA-infected corneas 24 hpi. By this time, a large number of CXCR3-positive cells were detected in the control corneas, located mostly at the posterior side, while CXCL10-positive cells were found both in the epithelial layer and the stroma. As CECs are generally CXCR3-negative, the epithelial cell-derived CXCL10 is likely to recruit other immune cells from the limbal region rich in blood supply including macrophages and NK cells. As such, it is of great interest to identify CXCR3 and/or CXCL10 positive cells in CA-infected cells.
The staining pattern of NK1.1 is similar to CXCR3 in CA-infected corneas, suggesting that the infiltrated CXCR3-positive and/or CXCL10 high cells are indeed NK or NK T cells. Our study using Rag1KO mice ruled out the involvement of NK T cells. Hence we concluded that the CXCR3-positive cells in CA-infected cornea are indeed NK cells. Interestingly, the NK1.1-positive cells are also CXCL10-positive, suggesting a possible autocrine signaling in the recruited NK cells. Alternatively, CXCL10 expressed by the epithelium binds to CXCR3 on the surface of the NK cells, resulting in CXCL10 high cells. In the CA-infected cornea, the cells expressing abundant CXCL10 and CXCR3 were found to form densely packed clusters on the top of and underneath the thin epithelial layer in a lesion (infection) site. These cells are also positively stained with NK1.1. We postulate that NK cells surround invading CA to form densely packed clusters in which CA were eradicated. This is consistent with a recent report showing human NK cells are capable of ingesting CA, resulting in their activation and in killing these microbes by secreting perforin [43] . Moreover, the activated NK cells may also be indirectly involved in fungal clearance by modulating neutrophil antifungal activity [43] . It is interesting to note that when NK cells are neutralized, there are more neutrophils present and severe tissue damage (Fig. 6 ), similar to that observed in dextran sodium sulfate induced colitis in mice [44] . One potential role of NK cells is to regulate neutrophil function in a context-dependent manner: NK cells are activated upon encountering CA and activate neutrophils [43] ; when CA are being eliminated by NK-cell released perforin [43] and/or by NK-activated neutrophils, NK cells may induce neutrophil apoptosis [45] . In addition, NK cells may also participate in tissue repair in the cornea as demonstrated recently in the epithelial wound model [46, 47] . Consistent with NK cells as a critical component of innate immunity, our NK-cell depletion study revealed severe keratitis in the absence of NK cells, including corneal ulcers and potential fungal dissemination to the anterior chamber. The other known effectors cells are neutrophils, which we have shown to be critical for flagellin-induced protection [14, 19] . Recent studies showed that a unique population of BM neutrophils produce and respond to IL-17 [48, 49] . These neutrophils can be induced to produce ROS in response to IL-17, resulting in an increase in fungal killing in vitro and in a model of Aspergillus-induced keratitis. These studies suggest a role of IL-17 in corneal innate defense [48, 49] . The mechanisms underlying NK recruitment, activation, fungicidal activity, and their interaction with other immune, particularly neutrophils, and residential cells in response to infection are under investigation in our laboratories. Finally, we tested the therapeutic potential of CXCL10 and demonstrated that the administration of this chemokine prior to pathogen inoculation significantly alleviated CA keratitis. More importantly, the topical application of CXCL10 at 6 hpi was still effective in accelerating the resolution of infection-associated inflammation and in inhibiting infection and inflammation induced hem-and lymphangiogenesis (Gao and Yu, unpublished results). Hence, CXCL10 has the potential to be used as an adjunctive therapy to reduce microbial keratitis-induced tissue damage.
Materials and methods
Fungi
CA strain SC5314, a clinical isolate capable of producing experimental keratomycosis, was cultured on YPD agar (Sigma) for 3 days at 25°C. Colonies were harvested after 3 days of inoculation and diluted in sterile PBS to yield 2 × 10 5 CFU/μL based on the OD at 600 nm, using a predetermined OD 600 conversion factor of 1 OD = 3 × 10 7 CFU/mL [15] . 
Animals
Flagellin preparation, pretreatment, and infection procedure
Flagellin was prepared from P. aeruginosa strain PA01 as described earlier [16, 50] . The bioactivity of each preparation was compared with previous samples for their ability to induce tolerance in cultured human CECs [51] . For flagellin pretreatment, mice (n = 5/group/treatment) were anesthetized with ketamine/xylazine and placed beneath a stereoscopic microscope at a magnification of 40×, and the corneas were scratched gently with three 1 mm incisions using a sterile 26-gauge needle. Purified flagellin (500 ng in 5 μL of PBS) or PBS for the control was applied to the injured corneas of the same mice (one serves as the control for the other; the data were presented as the number of eyes). After 24 h, corneas were excised and processed for CXCL10 and CXCR3 expression. For corneal infection, mice were anesthetized, the pretreated corneas were rescratched 24 h postflagellin application, and a 5 μL suspension containing a 1 × 10 5 CFU of CA strain SC5314 was applied to the surface of the scarified cornea. The anesthetized mice were kept on a fixed position with the instilled solution remaining on the ocular surface until they awakened (usually >20 min).
Clinical scoring
For the assessment of clinical scores, the mice were color-coded and examined by two independent observers daily, one with the knowledge of codes and the other in a blind fashion, and photographed at 1, 3, 5, or 7 days after infection (dpi). If there was a conflict in clinical scoring, a third person, usually the corresponding author, would perform scoring from photographs. Ocular disease was graded in clinical scores ranging from 0 to 12, according to the scoring system developed by Wu et al. [52] . A grade of 0-4 was assigned to each of the following three criteria-area of opacity, density of opacity, and surface irregularity-resulting in a potential total score of 12. At the indicated time, all infected corneas were photographed with a slide lamp or a dissection microscope to illustrate the disease progression.
Fungal load determination, cytokine ELISA, and MPO measurement
We used our previously modified methods that allowed all three assays (fungal load, MPO determination, and cytokine ELISA measurement) to be performed with a single mouse cornea. Briefly, the corneas were excised from the enucleated eyes, minced, and homogenized in 100 μL PBS. The homogenates were divided into two parts, one for plate fungal counting and the other for cytokine ELISA and MPO measurements [14] . In each experiment, the controls without flagellin pretreatment were expected to have 2000-5000 CFU recovered, while flagellin pretreatment eradicated invading pathogens (<10 CFU/cornea) at 1 dpi.
RT-PCR and real-time PCR
Mouse cornea RNA was extracted using RNeasy Mini Kit (Qiagen), according to the manufacturer's instructions. cDNA was generated with an oligo(dT) primer (Invitrogen) followed by analysis using real-time PCR with the Power SYBR Green PCR Master Mix (AB Applied Biosystems, University Park, IL) based on the expression of β-actin. Generated cDNA was amplified by PCR by using primers for mouse Cxcl10, Cxcr3, and β-actin. The PCR products and the internal control β-actin were subjected to electrophoresis on 1% agarose gels containing ethidium bromide. Stained gels were captured by using a digital camera. The following primer pairs were used: 5 -GACGGCCAGGTCATCACTATTG-3 , 5 -AGGAAGGCTGGAAAAGAGCC-3 for β-actin, 5 -CCATCAGCA CCATGAACCCAAGT-3 , 5 -CACTCCAGTTAAGGAGC-3 for Cxcl10, 5 -GATCAAACCTGCCTAGATCC-3 , 5 -GGCTGTGTAGA ACACAGAGT-3 for Cxcl9, 5 -ATTACCAGGCTGCAGAACTTT-3 , 5 -TCTTCCTAGATGTTCGTGTGC-3 for Cxcl11, and 5 -AGAATC ATCCTGGTCTGAGACAA-3 , 5 -AAGATAGGGCATGGCAGCTA-3 for Cxcr3.
Immunohistochemistry
At the indicated times, the corneas were excised from sacrificed mice and were frozen in Optimal Cutting Temperature (OCT) compound; posterior parts along with the lens were removed after the global parts were just frozen. The corneas were cut into 6 μm thick sections by cryostat sectioning and the sections were mounted to polylysine-coated glass slides. After a 10 min fixation in 4% paraformaldehyde, the sections were blocked with 10 mM PBS, containing 2% BSA, for 1 h at room temperature. Sections were then incubated with primary antibodies: rabbit anti-mouse CXCL10 (Peprotech; 1:100), CXCR3 (Abnova, 1:250), followed by the secondary Ab, Cy3-conjugated goat anti-rabbit IgG (Jackson Immunoresearch Inc), with or without FITC-labeled anti-mouse NK1.1 (eBiosciences; 1:100). Slides were mounted with DAPI mounting media. Controls were similarly treated, but the primary Ab was replaced with nonspecific rabbit IgG.
CXCL10, CXCR3, and NK1.1 neutralization
Mice were anesthetized as prescribed and rabbit antimurine CXCL10 or CXCR3, anti-mouse NK1.1 (clone PK136) (2.5 μg/5 μL, Abnova) were injected subconjunctivally, 2.5 μg/5μL, 6 h before CA infection.
In vitro assay of antifungal activity of recombinant CXCL10
For recombinant CXCL10, 400 μL PBS with different concentrations of recombinant mouse CXCL10 were incubated with 1 × 10 4 CFU CA at 37°C for 2 h. Serial dilutions of each reaction mixture were made to inoculate YPD agar plates. Samples (100 μL) were spread evenly over the surface of the plates with sterile glass spreaders. After incubation at 25°C for 72 h, the number of colonies was counted. Experiments were repeated once.
To determine whether CECs expressing CXCL10 possessed fungicidal activity, HUCL cells (a human CEC line [53] ) were cultured on 12-well tissue culture plates (Costar), and then were transfected with 1.5 × 10 11 CFU AAV2 (recombinant adenoassociated virus vector-2) with inserted DNA that encoded the human CXCL10 with green fluorescence protein as the control (a gift from Dr. Xiao Xiao, University of North Carolina at Chapel Hill). The transfected cells expressed high levels of the target genes at day 3. At day 3 post-AAV2 infection, cells were cultured in 1 mL fresh defined keratinocyte-a serum-free medium (Invitrogen-Life Technologies, Carlsbad, CA)-for 24 h and the culture media were then collected and used for in vitro assay of antifungal activities as described for recombinant CXCL10.
Statistical analysis
Data were presented as the means ± SD. Statistical differences among three or more groups were identified using one-way ANOVA. Differences were considered statistically significant at p < 0.05. Between two groups, an unpaired, two-tailed Student's t-test was used to determine statistical significance for data from fungal counts, cytokine ELISA, and the MPO assay. A nonparametric Mann-Whitney U-test was performed to determine statistical significance for clinical scores. Experiments were repeated at least twice to ensure reproducibility.
